Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Completed 6Withdrawn 3Recruiting 3Unknown 2Terminated 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1CNS 1Breast 1

Conditions

Motor Activity 1Lymphoma 1Leukemia 1Hypertension, Portal 1Esophageal and Gastric Varices 1Cardiotoxicity 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Interventional × Carvedilol × Clear all
NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

SWOG Cancer Research Network

Phase 3 Recruiting
491 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

NCT06594744 2025-02-13

P-HCC-CVL

Taipei Veterans General Hospital, Taiwan

Phase 4 Recruiting
120 enrolled
Gastrointestinal

Esophageal and Gastric Varices, Carcinoma, Hepatocellular, Hypertension, Portal

NCT06643221 2024-10-16

Allo-X

University of Arizona

Phase EARLY_PHASE1 Recruiting
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡